New drug ABBV-932 passes early safety check in healthy volunteers
NCT ID NCT07024797
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This early-stage study tested the safety and how the body handles ABBV-932, an experimental oral drug, in 20 healthy Chinese adults. Participants received multiple doses to measure how the drug moves through the body and to check for side effects. The goal was not to treat any disease, but to gather important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Mental Health Center /ID# 273427
Shanghai, Shanghai Municipality, 200030, China
Conditions
Explore the condition pages connected to this study.